Delivery Order SPE2DB24D1205-SPE2DB24FCULM

Award Date 9/6/24
Potential Completion Date 9/9/24
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of VYVANSE 20 MG CAPSULE 100S. The contract has a ceiling value of $1,600.66 and a period of performance through April 29, 2024. It is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VYVANSE 20 MG CAPSULE 100S. The total ceiling value of the contract is $1,535.33 and the ultimate completion date is April 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp with a potential value of up to $999,999,999.00 and a...
The federal contract award, SPE2DB25D2204|SPE2DB25FTFXT, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,173.83 firm fixed-price delivery order contract, with a completion date of January 8, 2025, is for the supply of 4566861069 - VYVANSE 20 MG CAPSULE 100S. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $2,129.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of VYVANSE 40 MG CAPSULE 100S. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical...
This federal contract award, with an ID of SPE2DB20D1100|SPE2DB25FZ20U, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $2,784.96, is a delivery order for the supply of 4566529414 - VYVANSE 10 MG CAPSULE 100S. The contract has a firm fixed price and an ultimate completion date of November 25, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical is for the supply of VYVANSE 50 MG CAPSULE 100S, a prescription medication, with a ceiling value of $6,503.14. The award is a delivery order under an Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables the DLA to procure a comprehensive range of medical commodities from Amerisourcebergen to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,658.67, is a delivery order for the supply of VYVANSE 40 MG CAPSULE 100S, a prescription medication. The contract has a ceiling value of $1,658.67 and a period of performance through December 27, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of VYVANSE 20 MG CAPSULE 100S. The contract is a Delivery Order with a Firm Fixed Price of $2,675.40 and an ultimate completion date of January 29, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,033.44 firm fixed-price delivery order is for the supply of VYVANSE 10 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of August 16, 2024 and was awarded on August 15, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of VYVANSE 20 MG CAPSULE 100S. The contract, valued at $4,460.30, has a completion date of June 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB24FCULM
    Delivery Order

The federal contract award SPE2DB24D1205/SPE2DB24FCULM was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VYVANSE 20 MG CAPSULE 100S. The contract has a ceiling value of $3,017.00 and is a Firm Fixed Price Delivery Order with a completion date of September 9, 2024. Amerisourcebergen has been awarded this contract under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This contract award does not utilize any set-aside designations.

Generated 12/6/24, 9:17 AM